In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

PBM's serve as middlemen between drug makers, insurers, and pharmacies. A new report from the FTC claims the companies made more than seven-billion dollars by marking up the prices of generic ...

One is “spread pricing,” when a PBM charges its health plan clients ... (If Trump promising to eliminate the middlemen sounds familiar, it’s because he said the same thing about PBMs in ...

It is time to stop the pharmacy benefit manager (PBM) middlemen from inflating Americans' drug prices, from barring access to Americans' pharmacy of choice, and from forcing pharmacies out of ...

"You got to figure out how to work with him, right?" PBM reform is top of mind for drugmakers. They argue that the middlemen overcharge insurance plans for which they negotiate medication rebates ...